VANGUARD GROUP INC 13D and 13G filings for Astria Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 1:29 pm Unchanged | 2024-09-30 | 13G | Astria Therapeutics, Inc. ATXS | VANGUARD GROUP INC | 2,635,520 4.670% | 0 (Unchanged) | Filing |
| 2024-11-04 12:37 pm Unchanged | 2024-09-30 | 13G | Astria Therapeutics, Inc. ATXS | VANGUARD GROUP INC | 2,635,520 4.670% | 0 (Unchanged) | Filing |
| 2024-11-04 11:39 am Unchanged | 2024-09-30 | 13G | Astria Therapeutics, Inc. ATXS | VANGUARD GROUP INC | 2,635,520 4.670% | 0 (Unchanged) | Filing |
| 2024-11-04 11:39 am Purchase | 2024-09-30 | 13G | Astria Therapeutics, Inc. ATXS | VANGUARD GROUP INC | 2,635,520 4.670% | 579,813 (+28.21%) | Filing |
| 2024-02-13 4:58 pm Purchase | 2023-12-29 | 13G | Astria Therapeutics, Inc. ATXS | VANGUARD GROUP INC | 2,055,707 5.660% | 2,055,707 (New Position) | Filing |